Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion type Assertion NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_head.
- NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion description "[The effect of Mcl-1L shRNA or Obatoclax (a small molecule Mcl-1 inhibitor), in combination with Cisplatin on chemosensitivity of oral cancer cells was also assessed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_provenance.
- NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion evidence source_evidence_literature NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_provenance.
- NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion SIO_000772 25409302 NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_provenance.
- NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion wasDerivedFrom befree-2016 NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_provenance.
- NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_assertion wasGeneratedBy ECO_0000203 NP1238550.RA4CPvnfrZgWnYuOl9_PUXhCSJEA4z-wkxydZlYYfjEiU130_provenance.